LABOTHERM PURDUE PHARMA SIGN TRAMADOL PACT An article from Biotech Business
LABOTHERM PURDUE PHARMA SIGN TRAMADOL PACT An article from Biotech Business
This digital document is an article from Biotech Business, published by Thomson Gale on October 1, 2005. The length of the article is 929 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: LABOTHERM/PURDUE PHARMA SIGN TRAMADOL PACT.
Publication: Biotech Business (Newsletter)
Date: October 1, 2005
Publisher: Thomson Gale
Volume: 18 Issue: 10 Page: NA
Distributed by Thomson Gale
Related Blogs
Filed under: Book
Like this post? Subscribe to my RSS feed and get loads more!
Possibly related posts
- LABOPHARM PURDUE PHARMA SIGN TRAMADOL LICENSING PACT An article from Worldwide Biotech
- Refractory osteoarthritis pain may respond to opioid treatment tramadol buprenorphine News An article from Internal Medicine News
- Osteoarthritis pain may respond to opioids tramadol buprenorphine top options Clinical Rounds An article from Family Practice News
- The effects of tramadol on pain relief fast EEG power spectrum and An article from Acute Pain
- Abuse liability behavioral pharmacology and physical dependence potential of opioids in humans and laboratory animals Lessons from tramadol An article from Biological Psychology
Leave a Reply